Fever is an adaptive response to a variety of infectious, inflammatory, and foreign stimuli. The "febrile response" confers an immunological advantage to the host over invading microorganisms -bacterial, fungal and viral. Fever results from a cytokine-mediated reaction that results in the generation of acute phase reactants and controlled elevation of core body temperature. The anterior hypothalamus coordinates the "febrile response" in reaction to the release of endogenous pyrogenes and subsequent up-regulation of prostaglandin synthesis. An ensuing change in the hypothalamic set point for temperature regulation advances a synchronized physiologic response from CNS to periphery, on a microscopic and macroscopic level, throughout the entire human organism. This differs from hyperthermia which refers to heat retention attributable to unregulated readjustment of the thermoregulatory mechanism. Clinically, an elevation of core body temperature, whether in fever or hyperthermia, is only the most apparent manifestation of an intricate mechanism that orchestrates activation of autonomic, immunologic, neurologic, hematologic, endocrine and behavioral responses. Fever has been classically described as having three phases. 1 In the "initiation phase," cutaneous vasoconstriction diverts blood from the body's surface to its core. Simultaneously, a broad sympathetic impulse commences rigors (shivering) as opposing muscles groups contract to contribute to excess heat production. The shunting of blood from epithelium to core organs and the increase in metabolic activity leads to the elevation of body temperature. In the "plateau phase," heat production and heat loss equalize and the body maintains an elevated temperature through rigors and diaphoresis. In the third phase, or "defervescence," cutaneous vasodilation and diaphoresis lead to dissipation and loss of excess heat, thus allowing the body temperature to drop back to normal.
Hyperthermia occurs when there is disturbances to the central mechanisms of thermoregulation and heat dissipating mechanisms have been compromised. Although the exact mechanisms are unknown, "hyperthermia-induced brain injury" has been speculated to cause direct damage to thermoregulatory centers thus obliterating feedback to the temperature set point elevation. 2 Some have hypothesized that brain injury induces disruption of mesencephalic-diencephalic physiology responsible for tonic inhibition of thermogenesis and the overriding effects of sympathetic activation which impair peripheral mechanisms of heat dissipation. 3 Contrary to the normal processes associated with infectious fever, hyperthermia presents as an elevated body temperature in association with the absence of diaphoresis, tachypnea, and tachycardia. 4 Other characteristics distinguishing hyperthermia from fever include: an inordinately high temperature (greater than 41 C) that may persist for days to weeks, a lack of diurnal variation, a plateau-like pattern of elevations and maintenance. 4 Interestingly, appropriate treatment hinges upon correct diagnosis of fever versus hyperthermia, as elevated temperature with hyperthermia is lowered more effectively by external cooling than by antipyretic agents. Although the causes of this phenomenon remain speculative, the neurologic effects of fever with traumatic brain injury, intracerebral hemorrhage, subarachnoid hemorrhage and post-operative recovery are significantincreased temperature has been associated with increased local cytokine activity, increased infarct size, increased intracranial pressure, vasospasm, symptomatic vasospasm, ischemic brain injury and poor outcomes in the acute phase of neurologic injury.
Infectious Fever versus Non-Infectious Fever
In the NICU setting, fevers are classified as "infectious" or "non-infectious". 5 Clinicians further characterize them as either "explained" or "unexplained" according to clinical findings, laboratory tests, or imaging studies that elucidate their etiology. 6 For example, pneumonia is an "explained" and "infectious" cause of fever, confirmed by leukocytosis, purulent tracheal secretion, positive sputum cultures and infiltrate on chest radiograph. On the other hand, atelectasis is an "explained" but "non-infectious" cause of fever confirmed by characteristic findings in two or more lung segments without leukocytosis or positive sputum cultures. Further still, central neurogenic fever or post-traumatic hyperthermia is an "unexplained" and "noninfectious" cause of fever without confirmatory testing or sufficiently descriptive imaging studies. Central fever is speculated to result from damage to hypothalamus, midbrain, or pons enhanced by increased sympathetic activity, opening of the ventricles, damage to the frontal lobes, physical distortion, diffuse axonal injury, or toxic blood metabolites. 8 
Implication of Fever, both Infectious and Non-Infectious, in the NICU
In the critically-ill neurologic or neurosurgical patient, fever is a double-edged sword, characterized by both beneficial and detrimental effects on the acutely injured central nervous system. The beneficial effects include enhanced resistance to infection, local activation of the coagulation cascade, cytokine-mediated T-cell activation, as well as, neutrophil and macrophage recruitment to injured tissues. In the critically-ill patient, the protective effect of fever An abnormal elevation of body temperature, usually as a result of a pathologic process.
Hyperthermia, induced
Abnormally high temperature intentionally induced in living things regionally or whole body. It is most often induced by radiation (heat waves, infra-red), ultrasound, or drugs.
Malignant hyperthermia
Rapid and excessive rise of temperature accompanied by muscular rigidity following general anesthesia against the development of infection generally offset the dangers. Unfortunately, the patient that has suffered an acute insult to the CNS is an exception. After the initial injury, secondary brain insults are speculated to be caused by several processes including mitochondrial dysfunction, inflammatory response, free radical generation, and excitatory neurotransmitter release. 9 These episodes of secondary brain injury appear to be caused by or temporally associated with hypotension, intermittent hypoxia and ischemia, fever and hyperthermia, cerebral hypertension and elevated intracranial pressure. 9 In terms of trauma to the CNS, it is commonly accepted that elevated temperature exacerbates secondary brain injury. Fever has been demonstrated to increase glutamate release, provoke diffuse oxygen free radical production, increase cytoskeletal protein degradation, and markedly augment the permeability of the bloodbrain barrier. 10 Increased permeability allows activated immune cells to acquire increased access to the interstitial space. Furthermore, vasogenic edema leads to increased fluid in the extracellular space and accumulation of intracellular fluid resulting in cytotoxic edema.
Despite evidence suggesting that hyperthermia does not impact the partial pressure of oxygen 11 or a causal relationship between elevated brain temperature and increased intracranial pressure, 12 current therapy suggests otherwise. Fever exacerbates ischemic neuronal damage and physiologic dysfunction after acute traumatic brain injury, subarachnoid hemorrhage, and major neurosurgery. 13 In addition to the aforementioned effects, fever also increases circulating catecholamines boosting cardiovascular output to meet heightened metabolic demands, further taxing the already damaged CNS. In sum, the physiologic response to fever in the CNS has been assumed to contribute deleterious effects that exceed any potential benefits of staving off infection.
Relevance to the Neurosurgical Patient
At least half of febrile incidents in the ICU are of non-infectious origin 5 In the neurocritical and neurosurgical patients the incidence and prevalence of non-infectious fever are even greater. Febrile episodes occur in roughly 50% of patients in the NICU with neurocritical patients having a slightly lower frequency of fever, approximately 23%, 6 than patients in the neurosurgical ICU, approximately 47%. 14 Fever in the neurocritical and neurosurgical patient population predominates with vascular injuries, such as intracerebral hemorrhage and subarachnoid hemorrhage. The highest rates of febrile episode occur in patients with subarachnoid hemorrhage (65%), followed by traumatic brain injury (40%) and intracranial hemorrhage (31%); no cause of fever was identified in 28% of patients, suggesting fever of central origin. 6 Fever has been linked to an increase in the length of stay, subsequent onset of further febrile episodes. Multiple studies have demonstrated that "non-infectious fever" is common in both the neurocritical and neurosurgical ICU patient population. Fever also tends to predominate amongst patients that have suffered either intracranial injury or traumatic brain injury as compared to spinal disorders.
Infectious Fever in the NICU
A new fever in an ICU patient can have a multitude of infectious and non-infectious etiologies. The practice guidelines from the Task Force of the Society for Critical Care Medicine (SSCM) and Infectious Disease Society of America (IDSA) urge for a "careful clinical assessment" and "cost-conscious approach" to obtaining a diagnosis through laboratory or radiological tests. 15 The SSCM and IDSA Task Force recommend perpetual reflection on the impact of diagnostic testing and radiological imaging with respect to patient harm, further nosocomial infection risks, and the likelihood of legitimate life-sparing intervention. They argue that "infection be considered regardless of temperature but that laboratory tests for infection should be initiated for febrile patients only if clinical assessment indicates a reasonable possibility that infection might be present". 15 The common causes of infectious fever in a NICU patient are the same as those for any critically ill patient. However, specific considerations should be made for nosocomoial infections secondary to depressed level of consciousness and surgical opening of the cranial vault. In a 2003 article, Commichau et al. 6 reported that fever was associated with infection in 50% of the 387 patients admitted to the Columbia University Hospital NICU. In a European 2002 study, Stochetti et al. 10 reported similar infection rates, again acknowledging pneumonia as the most frequent infection in head-injured patients. The most common infectious causes of fever in the NICU (10-20% of patients in the ICU) are presented in Table I .
The high incidence of nosocomial infections (NI) amongst patients admitted to Intensive Care Units (ICUs) are equally relevant to patients admitted to Neurocritical and Neurosurgical ICUs (NICUs). In the neurocritical and neurosurgical patient populations, nosocomial infection rates also depend on the severity of illness at presentation (i.e, Grade of SAH) and the exposure to invasive devices such as ventilators, central venous catheters and urinary catheters in addition to neuroscience specific devices, such as ventricular catheters. In the U.S., nosocomial infection rates in ICUs are tracked by the "National Nosocomial Infections Surveillance" System (NNIS) run by and published annually by the CDC. Unfortunately, the NNIS does not collect or analyze data specific to the NICU setting, thus there is a paucity of data available on the incidence of NI in the neurocritical or neurosurgical patient population.
In 1997, Dettenkofer et al. 16 began a prospective study in a ten-bed NICU tracking the incidence of nosocomial infections over a 30-month study period. They reported data on 505 patients with a total of 4,873 patient days and 122 NI amongst 96 patients (74 patients with one NI, 18 patients with two NI's, 4 patients with three NI's). The overall incidence of NI in the NICU was 24% (24.2 per 100 patients with a incidence density of 25.0 per 1,000 patient days), with nosocomial pneumonia (11.7%) and urinary tract infections (8.7%) the most frequent cause of infection, respectively. Interestingly, of the 59 nosocomial pneumonias, only 22 (37%) were ventilator-associated while 37 (63%) non-ventilator-associated. Contrary to data on medical-surgical ICUs, more than half the cases of nosocomial pneumonia were non-ventilator associated, which corresponds to decreased ventilator usage among NICU patients. Furthermore, the incidence of nosocomial pneumonias can probably be accounted for by the known high risk of aspiration pneumonia for patients with a depressed level of consciousness. With respect to UTI's, the incidence of NI's were strongly associated with device utilization (42 of 44 UTI's were device-associated). The incidence of bloodstream infections and other catheter related infections (local infections) were relatively low when compared to the incidence of pneumonias and UTI's (1.4% and 1.2%, respectively). Finally, the incidence of ventriculitis and meningitis were also extremely low (0.8% and 0.4%, respectively) when also compared to other NI's.
Non-Infectious Fever in the NICU, Explained and Unexplained Etiology
The patient with classic protracted fever in the NICU setting requires a methodical approach. Given the ramifications, an infectious cause is always presumed and its etiology sought for any critically ill patient with new onset of fever Avoidance of fever and hyperthermia remains a major aim in the management of patients in the NICU. However, this goal is not commonly achieved given the uncertain etiology of a potentially infectious or non-infectious fever. A fundamental principle in this setting is that the management of a classic fever of unknown origin is that "therapy should be withheld, whenever possible, until the cause of fever has been determined, so that it can be tailored to a specific diagnosis". 7 Within the non-infectious etiologies, there are four subcategories of non-Infectious fever which are the following: -1) , C-reactive protein (CRP), tumor necrosis factor-α, and interleukin-6. From all the above biomarkers, serum procalcitonin assay is approved for early detection of bacterial infection/sepsis during the first day of ICU admission, while the rest have yet to be validated.
The treatment of neurocritical or neurosurgical patients with central neurogenic fever hinges upon the axiomatic decision to declare a fever to be of infectious or non-infectious cause. For instance, to operate on the presumption that a patient has an infection until proven otherwise demands the utilization of rigorous empiric antibiotics regimens. The use of these medications is far from benign. In the ICU setting with all its innate risk factors for nosocomial infections, empiric antibiotic utilization can lead the patient to be unnecessarily exposed to courses of antibiotics with inherent toxicities, drug interactions and side effects that are conceivably detrimental to recovery or elucidation of the fevers origin. Furthermore, a response to antibiotics is an unreliable criterion for diagnosing or excluding bacterial or viral CNS infection, especially in the context of neurocritical or neurosurgical patients with intrinsic risks for non-infectious fever anyway.
Conclusion: Treatment Implications of Infectious versus Non-Infectious Fever
Clinical signs of fever are frequent in neurocritical and neurosurgical patients, and antibiotics are often administered without proof of infection. The clinical characteristics of patients with infectious fever and non-infectious fever markedly overlap. Classical markers of infection cannot differentiate reliably between inflammation and infection after neurosurgery. 17 The neurosurgical patient having suffered a CNS insult but lacking a documented source of fever, has a central neurogenic fever or post-traumatic hyperthermia by definition. To make the diagnosis of non-infectious unexplained fever (central neurogenic fever or post-traumatic hyperthermia) the clinician must have a high index of suspicion. On the NICU, the clinician combats inherent limitations of the physical exam and neurological exam, while racing against the incubation period for cultures, and exponential growth curve of infectious organisms in vivo. The critical sequelae of either untreated infections or unmanaged central neurogenic fever are urgent dilemmas in the neurocritical and neurosurgical intensive care setting. Regardless, the adverse effects of temperature elevation on neurological recovery are clear. The maxim that "time is tissue" and now "temp is tissue" demands further investigation and further trials of antipyretic medications, anti-hyperthermia strategies such as intravascular cooling techniques in addition to surgical interventions for tissue sparing before the onset of further ischemic damage or coagulative necrosis in the CNS.
